Anamaria Cozma-Petruț

Dr. Anamaria Cozma-Petruț

Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca Romania
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in World Journal of Gastroenterology
Verified
Journal Article
Open access
Anamaria Cozma-PetruțAnamaria Cozma-Petruț
Anamaria Cozma-Petruț
FLFelicia Loghin
Felicia Loghin
DMDoina Miere
Doina Miere
Dan L DumitrascuDan L Dumitrascu
Dan L Dumitrascu
A substantial proportion of patients with irritable bowel syndrome (IBS) associate their symptoms with the ingestion of specific foods. Therefore, in recent years, scientific research has increasingly focused on the role of diet in IBS and dietary management is now considered an important tool in IBS treatment. This article reviews the main dietary approaches in IBS emphasizing evidence from experimental and observational studies and summarizing the main diet and lifestyle recommendations provided by dietary guidelines and scientific literature. Despite the limited evidence for a beneficial role, general advice on healthy eating and lifestyle is recommended as the first-line approach in the dietary management of IBS. Standard recommendations include adhering to a regular meal pattern, reducing intake of insoluble fibers, alcohol, caffeine, spicy foods, and fat, as well as performing regular physical activity and ensuring a good hydration. Second-line dietary approach should be considered where IBS symptoms persist and recommendations include following a low FODMAP diet, to be delivered only by a healthcare professional with expertise in dietary management. The efficacy of this diet is supported by a growing body of evidence. In contrast, the role of lactose or gluten dietary restriction in the treatment of IBS remains subject to ongoing research with a lack of high-quality evidence. Likewise, further clinical trials are needed to conclude the efficacy of probiotics on IBS symptoms.

26 September 2022 in Plants
Verified
Journal Article
Open access
PDF file
MARIA VRANCEANUMARIA VRANCEANU
MARIA VRANCEANU
DGdamiano galimberti
damiano galimberti
RBRoxana Banc
Roxana Banc
Ovidiu DragoşOvidiu Dragoş
Ovidiu Dragoş
Anamaria Cozma-PetruțAnamaria Cozma-Petruț
Anamaria Cozma-Petruț
LFLorena Filip
Lorena Filip
Current studies show that approximately one-third of all cancer-related deaths are linked to diet and several cancer forms are preventable with balanced nutrition, due to dietary compounds being able to reverse epigenetic abnormalities. An appropriate diet in cancer patients can lead to changes in gene expression and enhance the efficacy of therapy. It has been demonstrated that nutraceuticals can act as powerful antioxidants at the cellular level as well as anticarcinogenic agents. This review is focused on the best studies on worldwide-available plant-derived nutraceuticals: curcumin, resveratrol, sulforaphane, indole-3-carbinol, quercetin, astaxanthin, epigallocatechin-3-gallate, and lycopene. These compounds have an enhanced effect on epigenetic changes such as histone modification via HDAC (histone deacetylase), HAT (histone acetyltransferase) inhibition, DNMT (DNA methyltransferase) inhibition, and non-coding RNA expression. All of these nutraceuticals are reported to positively modulate the epigenome, reducing cancer incidence. Furthermore, the current review addresses the issue of the low bioavailability of nutraceuticals and how to overcome the drawbacks related to their oral administration. Understanding the mechanisms by which nutraceuticals influence gene expression will allow their incorporation into an “epigenetic diet” that could be further capitalized on in the therapy of cancer.

31 July 2015 in Czech Journal of Animal Science
Verified
Journal Article
Open access
Anamaria Cozma-PetruțAnamaria Cozma-Petruț
Anamaria Cozma-Petruț
Sanda AndreiSanda Andrei
Sanda Andrei
Adela PinteaAdela Pintea
Adela Pintea
DMD. Miere
D. Miere
LFLorena Filip
Lorena Filip
AFA. Ferlay
A. Ferlay
Open Access Agricultural Journals published by Institute of Agricultural Economics and Information

20 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ITIoana Badiu Tișa²
Ioana Badiu Tișa²
AAAnca Cristina Achim
Anca Cristina Achim
Anamaria Cozma-PetruțAnamaria Cozma-Petruț
Anamaria Cozma-Petruț
Galactosemia is an inborn metabolic disorder caused by a deficient activity in one of the enzymes involved in the metabolism of galactose. The first description of galactosemia in newborns dates from 1908, ever since complex research has been performed on cell and animal models to gain more insights into the molecular and clinical bases of this challenging disease. In galactosemia, the newborn appears to be born in proper health, having a window of opportunity before developing major morbidities that may even be fatal following ingestion of milk that contains galactose. Galactosemia cannot be cured, but its negative consequences on health can be avoided by establishing precocious diagnosis and treatment. All the foods that contain galactose should be eliminated from the diet when there is a suspicion of galactosemia. The neonatal screening for galactosemia can urge early diagnosis and intervention, preventing complications. All galactosemia types may be detected during the screening of newborns for this disorder. The major target is, however, galactose-1-phosphate uridyltransferase (GALT) deficiency galactosemia, which is diagnosed by applying a combination of total galactose and GALT enzyme analysis as well as, in certain programs, mutation screening. Most critically, infants who exhibit symptoms suggestive of galactosemia should undergo in-depth testing for this condition even when the newborn screening shows normal results. The decision to enroll global screening for galactosemia among the specific population still faces many challenges. In this context, the present narrative review provides an updated overview of the incidence, clinical manifestations, diagnosis, therapy, and prognosis of galactosemia, questioning under the dome of these aspects related to the disease the value of its neonatal monitoring.

10 July 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
RBRoxana Banc
Roxana Banc
Daniela-Saveta PopaDaniela-Saveta Popa
Daniela-Saveta Popa
Anamaria Cozma-PetruțAnamaria Cozma-Petruț
Anamaria Cozma-Petruț
LFLorena Filip
Lorena Filip
BKBela Kiss
Bela Kiss
FLFelicia Loghin
Felicia Loghin
In recent years, it has been increasingly suggested that the consumption of natural polyphenols, in moderate amounts, is beneficial for health. The aim of this study was to investigate the efficacy of a red wine (the administered dose of 7 mL/kg/day being equivalent to ~16.5 mg/kg/day total polyphenols) compared to a white wine (the administered dose of 7 mL/kg/day being equivalent to ~1.7 mg/kg/day total polyphenols), on the prevention of acrylamide-induced subacute hepatic injury and oxidative stress in Wistar rats. Hepatic damage due to acrylamide intoxication (the administered dose being 250 µg/kg body weight, for 28 days, by intragastric gavage) was assessed by employing biochemical parameters (aspartate aminotransferase (AST) and alanine aminotransferase (ALT)) and by histopathological studies. Markers of oxidative damage were measured in terms of plasma malondialdehyde (MDA), hepatic Thiobarbituric Acid Reactive Substances (TBARS) and glutathione (GSH) levels, and liver antioxidant enzyme (superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx)) activities. Regarding hepatic enzyme activities, treatment with red wine significantly decreased the AST values (p < 0.05), while for the ALT values only a normalization tendency was observed. Treatment with red wine and white wine, respectively, significantly prevented the increase in MDA and TBARS levels (p < 0.05), as well as the depletion of GSH (p < 0.05). Red wine treatment normalized the activities of the antioxidant enzymes CAT and SOD in rats intoxicated with acrylamide, while supplementing the diet with white wine did not produce significant differences in the antioxidant enzyme activities. Histopathological findings revealed a moderate protective effect of red wine after four weeks of daily consumption. Our findings provide evidence that red wine, having a higher phenolic content than white wine, has a significant protective effect on oxidative stress and liver injury induced by acrylamide in rats, through its antioxidative activity.

23 November 2014 in Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Food Science and Technology
Verified
Journal Article
Open access
PDF file
RBRoxana Banc
Roxana Banc
Carmen SocaciuCarmen Socaciu
Carmen Socaciu
DMDoina Miere
Doina Miere
LFLorena Filip
Lorena Filip
Anamaria Cozma-PetruțAnamaria Cozma-Petruț
Anamaria Cozma-Petruț
FLFelicia Loghin
Felicia Loghin
Benefits of Wine Polyphenols on Human Health: A Review